Between 2000 and 2016 in the UK, the recorded prevalence of atrial fibrillation increased, accompanied by a significant improvement in appropriate anticoagulant prescribing for eligible patients.
From 2000 to 2016, the prevalence of recorded AF has increased in all age groups and both sexes. Anticoagulant treatment of eligible patients with AF has more than doubled, with marked improvements since 2011, alongside a reduction in the use of anticoagulants in ineligible patients with AF.
Adderley et al. (Tue,) studied this question.